Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07121920 · ClinicalTrials.gov registry record · NA
Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD
A NA study, sponsored by Cook Children's Health Care System.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07121920 is a NA study that has not yet begun recruiting, run by Cook Children's Health Care System. The registered enrollment target is 40 participants.
The verdict
NCT07121920, a NA study, has not yet begun recruiting, sponsored by Cook Children's Health Care System.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study aims to test the overall hypothesis that the membrane tissue binding capacity of cytokines in the biopsied tissue of patients with Inflammatory Bowel Disease (IBD) is predictive of/strongly correlated to clinical response/outcomes observed. The key questions under investigation are: Aim 1: To assess the fluorescent signal intensity at baseline (control antibody with control biopsy and control antibody with IBD biopsy). Aim 2: To characterize the cellular landscape by surveying surface markers using bar-coded antibodies and performing gene expression profiling on every cell within inflamed tissue of patients with IBD. Aim 3: Develop algorithm using artificial intelligence to predict responders versus non-responders and to further subclassify IBD patients using phenotype data.
Interventions
- DEVICE Confocal Laser Endomicroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07121920
The ClinicalTrials.gov registry entry for NCT07121920 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Children's Health Care System, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Confocal Laser Endomicroscopy is the first listed.
NCT07121920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07121920 about?
NCT07121920 is a clinical study titled "Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD". This study aims to test the overall hypothesis that the membrane tissue binding capacity of cytokines in the biopsied tissue of patients with Inflammatory Bowel Disease (IBD) is predictive of/strongly correlated to clinical response/outcomes observed. The key questions under investigation are: Aim...
What is the current status of trial NCT07121920?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-01. Estimated completion is 2028-07-01.
What interventions are being tested in trial NCT07121920?
The interventions under investigation include: Confocal Laser Endomicroscopy (DEVICE).
Who is sponsoring clinical trial NCT07121920?
This trial is sponsored by Cook Children's Health Care System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.